35.74
0.05 (0.15%)
| Penutupan Terdahulu | 35.68 |
| Buka | 35.78 |
| Jumlah Dagangan | 439,670 |
| Purata Dagangan (3B) | 571,368 |
| Modal Pasaran | 1,742,199,168 |
| Harga / Jualan (P/S) | 3.21 |
| Harga / Buku (P/B) | 3.22 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Feb 2025 - 17 Feb 2025 |
| Margin Keuntungan | -8.70% |
| Margin Operasi (TTM) | -6.39% |
| EPS Cair (TTM) | -0.830 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 17.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 16.59% |
| Nisbah Semasa (MRQ) | 3.62 |
| Aliran Tunai Operasi (OCF TTM) | 10.40 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 11.41 M |
| Pulangan Atas Aset (ROA TTM) | -3.51% |
| Pulangan Atas Ekuiti (ROE TTM) | -8.39% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | AtriCure, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.40 |
|
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.18% |
| % Dimiliki oleh Institusi | 105.56% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 61.00 (Canaccord Genuity, 70.70%) | Beli |
| Median | 40.00 (11.94%) | |
| Rendah | 36.00 (Oppenheimer, 0.74%) | Beli |
| Purata | 43.40 (21.45%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 33.99 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JP Morgan | 17 Dec 2024 | 40.00 (11.94%) | Beli | 31.50 |
| 30 Oct 2024 | 40.00 (11.94%) | Beli | 34.83 | |
| Canaccord Genuity | 09 Dec 2024 | 61.00 (70.70%) | Beli | 33.94 |
| 30 Oct 2024 | 53.00 (48.31%) | Beli | 34.83 | |
| Needham | 30 Oct 2024 | 40.00 (11.94%) | Beli | 34.83 |
| Oppenheimer | 30 Oct 2024 | 36.00 (0.74%) | Beli | 34.83 |
| UBS | 30 Oct 2024 | 40.00 (11.94%) | Beli | 34.83 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| NOZNESKY JUSTIN J | - | 33.31 | -585 | -19,486 |
| Jumlah Keseluruhan Kuantiti Bersih | -585 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -19,486 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 33.31 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| NOZNESKY JUSTIN J | Pegawai | 11 Dec 2024 | Dibuang (-) | 585 | 33.31 | 19,486 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 20 Nov 2024 | Pengumuman | AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference |
| 07 Nov 2024 | Pengumuman | AtriCure to Participate in the Stifel 2024 Healthcare Conference |
| 29 Oct 2024 | Pengumuman | AtriCure Reports Third Quarter 2024 Financial Results |
| 28 Oct 2024 | Pengumuman | AtriCure to Participate in the UBS Global Healthcare Conference |
| 15 Oct 2024 | Pengumuman | AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management |
| 08 Oct 2024 | Pengumuman | AtriCure to Announce Third Quarter 2024 Financial Results |
| 01 Oct 2024 | Pengumuman | AtriCure Receives CE-Mark for the EnCompass® Clamp |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |